CN103211932B - 一种治疗风湿痹症的中药组合物 - Google Patents
一种治疗风湿痹症的中药组合物 Download PDFInfo
- Publication number
- CN103211932B CN103211932B CN201310085696.8A CN201310085696A CN103211932B CN 103211932 B CN103211932 B CN 103211932B CN 201310085696 A CN201310085696 A CN 201310085696A CN 103211932 B CN103211932 B CN 103211932B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- composition
- medicine composition
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 206010072736 Rheumatic disease Diseases 0.000 title claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 201000010874 syndrome Diseases 0.000 claims description 18
- 230000000552 rheumatic Effects 0.000 claims description 17
- 241000522620 Scorpio Species 0.000 claims description 10
- 239000009490 scorpio Substances 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 241000131808 Scolopendra Species 0.000 claims description 9
- 210000000582 Semen Anatomy 0.000 claims description 9
- 230000000694 effects Effects 0.000 abstract description 25
- 208000002193 Pain Diseases 0.000 abstract description 19
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 210000004369 Blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 230000001737 promoting Effects 0.000 abstract description 7
- 229940079593 drugs Drugs 0.000 abstract description 5
- 231100000486 side effect Toxicity 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 2
- 241000208140 Acer Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 240000001992 Angelica archangelica Species 0.000 abstract 1
- 240000006432 Carica papaya Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 240000005801 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 240000004499 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000123866 Homalomena occulta Species 0.000 abstract 1
- 229940010454 Licorice Drugs 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 235000002354 carica papaya Nutrition 0.000 abstract 1
- 230000000295 complement Effects 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 210000003414 Extremities Anatomy 0.000 description 6
- 210000003205 Muscles Anatomy 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,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 data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nODVweCcgaGVpZ2h0PSc4NXB4JyB2aWV3Qm94PScwIDAgODUgODUnPgo8IS0tIEVORCBPRiBIRUFERVIgLS0+CjxyZWN0IHN0eWxlPSdvcGFjaXR5OjEuMDtmaWxsOiNGRkZGRkY7c3Ryb2tlOm5vbmUnIHdpZHRoPSc4NScgaGVpZ2h0PSc4NScgeD0nMCcgeT0nMCc+IDwvcmVjdD4KPHRleHQgeD0nMTMuMzEyOCcgeT0nNTMuNTkwOScgY2xhc3M9J2F0b20tMCcgc3R5bGU9J2ZvbnQtc2l6ZToyM3B4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6I0U4NDIzNScgPkg8L3RleHQ+Cjx0ZXh0IHg9JzI4LjE1NjknIHk9JzYyLjg2MzYnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6MTVweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID4yPC90ZXh0Pgo8dGV4dCB4PSczNS4wNDU1JyB5PSc1My41OTA5JyBjbGFzcz0nYXRvbS0wJyBzdHlsZT0nZm9udC1zaXplOjIzcHg7Zm9udC1zdHlsZTpub3JtYWw7Zm9udC13ZWlnaHQ6bm9ybWFsO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTpub25lO2ZvbnQtZmFtaWx5OnNhbnMtc2VyaWY7dGV4dC1hbmNob3I6c3RhcnQ7ZmlsbDojRTg0MjM1JyA+TzwvdGV4dD4KPC9zdmc+Cg== O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 210000002435 Tendons Anatomy 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000004634 feeding behavior Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000001717 pathogenic Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 231100000614 Poison Toxicity 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000000146 antalgic Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 230000025627 positive regulation of urine volume Effects 0.000 description 2
- 230000001105 regulatory Effects 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000001367 Arteries Anatomy 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 208000006111 Contracture Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 208000002173 Dizziness Diseases 0.000 description 1
- 206010015037 Epilepsy Diseases 0.000 description 1
- 206010015226 Erythema nodosum Diseases 0.000 description 1
- 210000003743 Erythrocytes Anatomy 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 210000000554 Iris Anatomy 0.000 description 1
- 210000001503 Joints Anatomy 0.000 description 1
- 210000003127 Knee Anatomy 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 210000003141 Lower Extremity Anatomy 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 206010044008 Tonsillitis Diseases 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressed Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000021271 drinking Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003419 expectorant Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001861 immunosuppresant Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001976 improved Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drugs Drugs 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 230000003014 reinforcing Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000002048 spasmolytic Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002522 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
Abstract
本发明涉及一种治疗风湿痹症的中药组合物，其是由下列重量份的中药原料组成：其是由下列重量份配比的中药原料组成：麻黄5-15份、秦艽10-20份、地枫10-20份、千年健10-20份、川乌5-12份、草乌5-12份、木瓜10-20份、伸筋草10-40份、甘草5-15份、鸡血藤10-40份、防风10-20份、桑枝10-20份、桂枝5-15份、桃仁5-15份、红花5-15份、当归10-20份、川牛膝10-20份、全虫5-15份、蜈蚣2-5份。本发明中药组合物的相互佐助，具有祛风除湿、活血祛瘀、散寒通络、温经止痛的功效，其治疗风湿痹症疗效显著，作用可靠，其组分药源广、配制简便、无毒副作用。
Description
技术领域
[0001] 本发明涉及一种传统草药的未确定结构的医用配制品，尤其是一种治疗风湿痹症的中药组合物。
背景技术
[0002] 风湿痹症是因风寒湿等邪杂合而致，侵袭人体，闭阻气血所发生的肢体关节肌肉疼痛、重着、麻木、肿胀、屈伸不利，甚则关节变形，或累及脏腑的一类病症。临床上有渐进性或反复发作性的特点。目前，临床上没有根治办法，用药治疗只是为了帮助病人减轻疼痛，也就是对症治疗。治疗用药主要为非留抗炎药、免疫抑制剂及激素，其长期用药的副作用大，症状缓解后停药易复发。
[0003] 中医认为风湿痹症与外感风寒湿热之邪和人体正气不足有关；主要病机是气血痹阻不通，筋脉关节失于濡养所致。另外饮食失调、外伤亦可以引起正气不足，上述诸多因素又往往相互影响，不可绝然分开。
[0004] 根据中医理论，针对风湿痹症的发病机理，进行辩证配伍组方，以达到标本同治的目的。
发明内容
[0005] 为了克服现有技术的不足，本发明提供一种配制方便、药源广、成本低、疗效显著、作用可靠、无副作用的治疗风湿痹症的中药组合物。
[0006] 本发明解决其技术问题所采用的技术方案是:一种治疗风湿痹症的中药组合物，其特征在于:其是由下列重量份配比的中药原料组成:麻黄5-15份、秦艽10-20份、地楓10-20份、千年健10-20份、川乌5-12份、草乌5-12份、木瓜10-20份、伸筋草10-40份、甘草5-15份、鸡血藤10-40份、防风10-20份、桑枝10-20份、桂枝5-15份、桃仁5-15份、红花5-15份、当归10-20份、川牛膝10-20份、全虫5-15份、蜈蚣2-5份。
[0007] 本发明的优选技术方案是:一种治疗风湿痹症的中药组合物，其特征在于:其是由下列重量份配比的中药原料组成:麻黄10份、秦艽15份、地楓15份、千年健15份、川乌8份、草乌8份、木瓜15份、伸筋草30份、甘草10份、鸡血藤30份、防风15份、桑枝15份、桂枝10份、桃仁12份、红花12份、当归15份、川牛膝15份、全虫10份、蜈蚣3份。
[0008] 本发明中药组合物是在传统中医理论和临床经验指导下，精选药物组方。本发明中药组合物中:麻黄具有发汗解表、宣肺平喘、利水消肿的功效；秦艽具有袪风湿、舒筋络、清虚热的功效；地楓皮具有祛风除湿、行气止痛的功效，用于风湿痹痛、腰肌劳损；千年健具有祛风湿、健筋骨、活血止痛的功效，用于风寒湿痹、腰膝冷痛、下肢拘挛麻木；川乌具有祛风除湿、温经止痛的功效；草乌具有搜风胜湿、散寒止痛、开痰消肿的功效；木瓜具有平肝舒筋、和胃化湿的功效；伸筋草有祛风散寒、除湿消肿、舒筋活血的功效；甘草具有补脾益气、清热解毒、祛痰止咳、调和诸药的功效；鸡血藤具有补血活血、舒经通络的功效；防风具有怯风解表、胜湿止痛、止疫定搞的功效；桑枝具有怯风湿、利关节、彳丁水气的功效；桂枝具有发汗解肌、温经通脉、助阳化气、散寒止痛的功效；桃仁具有活血祛瘀、润肠通便的功效；红花具有活血通经、散瘀止痛的功效；当归具有补血活血、调经止痛、润肠通便的功效；川牛膝具有逐瘀通经、通利关节、利尿通淋的功效；全虫，又名蝎子，具有熄风镇痉、消炎攻毒、通络止痛的功效；蜈蚣具有祛风镇惊、解毒散结、通络止痛的功效。本发明组合物中的药物组分经辩证配伍，相互佐助，共奏祛风除湿、活血祛瘀、散寒通络、温经止痛之功效，对风湿痹症达到标本同治的目的。
[0009] 本发明组合物的组分均采用天然的中药原料，其配制简便、药源广、成本低。其遵循中医的处方用药原则，各种组分药物采用水煎服用。经临床应用验证，其疗效显著，作用可靠，药性平和，未出现毒副作用，总有效率88.9%，治愈率达55.5%。
具体实施方式
[0010] 下面结合实施例对本发明做进一步说明。
[0011] 实施例1
[0012] 一种治疗风湿痹症的中药组合物，其是由下列重量配比的中药原料组成:麻黄10g、秦充15g、地楓15g、千年健15g、川乌8g、草乌8g、木瓜15g、伸筋草30g、甘草10g、鸡血藤30g、防风15g、桑枝15g、桂枝10g、桃仁12g、红花12g、当归15g、川牛膝15g、全虫10g、蜈虫公3go
[0013] 实施例2
[0014] 一种治疗风湿痹症的中药组合物，其是由下列重量配比的中药原料组成:麻黄5g、秦艽20g、地楓20g、千年健20g、川乌5g、草乌12g、木瓜10g、伸筋草20g、甘草15g、鸡血藤10g、防风10g、桑枝12g、桂枝15g、桃仁5g、红花5g、当归10g、川牛膝20g、全虫5g、蜈虫公
4g0
[0015] 实施例3
[0016] 一种治疗风湿痹症的中药组合物，其是由下列重量配比的中药原料组成:麻黄15g、秦艽1giW 10g、千年健12g、川乌10g、草乌5g、木瓜20g、伸筋草10g、甘草5g、鸡血藤40g、防风12g、桑枝10g、桂枝12g、桃仁8g、红花15g、当归12g、川牛膝18g、全虫8g、蜈虫公
2go
[0017] 实施例4
[0018] 一种治疗风湿痹症的中药组合物，其是由下列重量配比的中药原料组成:麻黄8g、秦充12g、地楓18g、千年健10g、川乌12g、草乌6g、木瓜18g、伸筋草15g、甘草8g、鸡血藤25g、防风20g、桑枝20g、桂枝8g、桃仁10g、红花8g、当归18g、川牛膝10g、全虫15g、蜈蚣5g。
[0019] 实施例5
[0020] 一种治疗风湿痹症的中药组合物，其是由下列重量配比的中药原料组成:麻黄12g、秦艽15g、地楓12g、千年健18g、川乌9g、草乌10g、木瓜12g、伸筋草25g、甘草12g、鸡血藤15g、防风18g、桑枝18g、桂枝5g、桃仁15g、红花10g、当归20g、川牛膝12g、全虫12g、蜈蚣3g。
[0021] 本发明实施例中的中药组合物按常规的水煎法制取药剂。具体方法如下:将组方的中药原料放入容器中，加冷水漫过药面，浸泡15〜20分钟，再加水没过药面约8厘米，进行煎煮，未沸前采用武火煎煮，沸后用文火煎煮20〜30分钟；第二煎煮，加水没过药面约5厘米，进行煎煮，水沸后煎煮15〜20分钟。两次煎煮去渣取汁，合并。
[0022] 一种治疗风湿痹症的中药组合物，临床疗效总结:
[0023] 一、一般性资料:本中药组合物应用于临床观察病例45例，其中男23例，女22例，年龄40〜70岁。病程最短者2个月，最长者达10年，平均4年。
[0024] 二、诊断依据:
[0025] 1、以四肢大关节走窜疼痛为主，伴重着、酸楚、麻木、关节屈伸不利。多有恶寒、发热等症；
[0026] 2、病前多有咽痛乳蛾史，或涉水淋雨、久居湿地史；
[0027] 3、部分患者可有低热，四肢环形红斑，或结节性红斑。常可心脏受累；
[0028] 4、血沉增快，抗链球菌素“O”大于500单位。
[0029] 三、用法用量:临床应用时，组合物中的组分、用量根据患者的体重、年龄及症状酌情增减。七天为一疗程，一天一剂，水煎两遍取汁约300ml，分早、晚两次饭前半小时温热服用。服药期间忌食生冷、辛辣、刺激之物。
[0030] 四、疗效标准:
[0031] 1、临床治愈:肢体关节疼痛消失，其他伴随症状恢复正常；
[0032] 2、好转:肢体关节疼痛明显减轻，其他伴随症状也明显好转；
[0033] 3、无效:肢体关节疼痛及伴随症状无明显改善。
[0034] 五、治疗效果:该临床观察病例中，服药1-10个疗程，治愈25例，好转15例，无效5例。治疗期间未发生毒副作用。
[0035] 六、典型病例:
[0036] 病例1:刘某，男，59岁，膝盖关节疼痛较剧，遇寒加重，得热痛减，痛处不红，触之不热。服用本发明的中药组合物制备的药剂3个疗程，关节肿胀消退，疼痛减轻；继续服用2个疗程后疼痛消失；继续巩固服用I个疗程，运动自如流利。
[0037] 病例2:杨某，女，68岁。关节局部红肿灼热，痛不可触，屈伸不利，得冷稍舒。服用本发明的中药组合物制备的药剂3个疗程，红肿减轻，疼痛减轻；继续服用2个疗程后关节红肿灼热消失，治愈。
Claims (1)
1.一种治疗风湿痹症的中药组合物，其特征在于:其是由下列重量配比的中药原料组成:麻黄10g、秦艽15g、地楓15g、千年健15g、川乌8g、草乌8g、木瓜15g、伸筋草30g、甘草10g、鸡血藤30g、防风15g、桑枝15g、桂枝10g、桃仁12g、红花12g、当归15g、川牛膝15g、全蝎10g、蜈蚣3go
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310085696.8A CN103211932B (zh) | 2013-03-18 | 2013-03-18 | 一种治疗风湿痹症的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310085696.8A CN103211932B (zh) | 2013-03-18 | 2013-03-18 | 一种治疗风湿痹症的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103211932A CN103211932A (zh) | 2013-07-24 |
| CN103211932B true CN103211932B (zh) | 2015-06-10 |
Family
ID=48810318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310085696.8A CN103211932B (zh) | 2013-03-18 | 2013-03-18 | 一种治疗风湿痹症的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103211932B (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103417774B (zh) * | 2013-09-05 | 2015-02-25 | 韩淑燕 | 一种中药制剂及其制备方法和用途 |
| CN104435472A (zh) * | 2013-09-13 | 2015-03-25 | 孙建民 | 一种治疗偏瘫的复原配方 |
| CN104548048A (zh) * | 2015-01-29 | 2015-04-29 | 马成英 | 一种治疗风湿筋骨病的中药组合物 |
| CN104689233A (zh) * | 2015-02-15 | 2015-06-10 | 孙红梅 | 一种治疗痹症的中药组合物 |
| CN105412276A (zh) * | 2016-01-07 | 2016-03-23 | 张志仁 | 一种祛风除湿治骨的纯中药 |
| CN107213225A (zh) * | 2017-05-17 | 2017-09-29 | 杨宇 | 一种用于止痛、促进骨生长的药物组合物及其应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1358532A (zh) * | 2001-12-03 | 2002-07-17 | 刘殿章 | 一种治疗痹证病的中药 |
| CN1490017A (zh) * | 2002-10-14 | 2004-04-21 | 何廷银 | 一种治疗类风湿、风湿类疾病的药物 |
| CN102526259A (zh) * | 2010-12-13 | 2012-07-04 | 陈冠卿 | 一种治疗类风湿性关节炎的药物 |
-
2013
- 2013-03-18 CN CN201310085696.8A patent/CN103211932B/zh not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1358532A (zh) * | 2001-12-03 | 2002-07-17 | 刘殿章 | 一种治疗痹证病的中药 |
| CN1490017A (zh) * | 2002-10-14 | 2004-04-21 | 何廷银 | 一种治疗类风湿、风湿类疾病的药物 |
| CN102526259A (zh) * | 2010-12-13 | 2012-07-04 | 陈冠卿 | 一种治疗类风湿性关节炎的药物 |
Non-Patent Citations (1)
| Title |
|---|
| 中药内外合治治疗类风湿性关节炎135例;郝瑞雪等;《中国民间疗法》;20090428;第17卷(第04期);44-45 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103211932A (zh) | 2013-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988657B (zh) | 一种治疗骨折及跌打损伤的膏药及其制备方法 | |
| CN101244252B (zh) | 一种消除疼痛的中药药贴及其制备方法 | |
| CN103893727B (zh) | 一种止痛活血舒筋贴膏及其制备方法 | |
| CN104147577B (zh) | 一种用于促进骨痂生长治疗骨折的膏药 | |
| CN102512565B (zh) | 一种治疗肾虚腰痛的中药组合物 | |
| CN103007216B (zh) | 一种治疗慢性腹泻的中药组合物 | |
| CN102813860B (zh) | 一种治疗风湿骨病膏药 | |
| CN101972453B (zh) | 一种治疗风湿类风湿关节炎的中药药酒及其制备方法 | |
| CN103055244B (zh) | 一种治疗风湿骨病的膏药及其制备方法 | |
| CN102793883B (zh) | 一种治疗椎间盘突出、颈椎病的膏药 | |
| CN1679843A (zh) | 治疗血栓闭塞性脉管炎的口服药 | |
| CN1803187A (zh) | 一种治疗腰间盘突出、骨质增生的中草药 | |
| CN103191383B (zh) | 一种治疗类风湿性关节炎的中药组合物 | |
| CN103893639A (zh) | 一种治疗风湿性类风湿关节炎的中药组合物及其制备方法 | |
| CN103028091B (zh) | 一种治疗肝胆湿热的中药组合物 | |
| CN103211885B (zh) | 一种治疗慢性荨麻疹的中药组合物 | |
| CN105477595A (zh) | 一种治疗冻疮的中药药剂 | |
| CN104288538A (zh) | 一种治疗颈肩腰腿疾病的膏药及其制备方法 | |
| CN1839941A (zh) | 一种消骨镇痛的中成药 | |
| CN105031088A (zh) | 一种治疗风湿关节炎的泡脚粉及其制备方法 | |
| CN103463349A (zh) | 一种治疗急性腰扭伤的中药组合物 | |
| CN104644943A (zh) | 中药组合物、含该组合物的药灸及制备方法 | |
| CN103550687B (zh) | 一种治疗肝肾阴虚的中药组合物 | |
| CN104189871A (zh) | 一种治疗骨质增生的药酒 | |
| CN102309723B (zh) | 一种治疗关节疼痛的中药组合物及其药膏的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LI XIN Free format text: FORMER OWNER: ZHAO XIA Effective date: 20150401 |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHAO XIA TO: LI XIN QU XIAORONG ZHAO XIA |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150401 Address after: 264309 No. 1118 the Yellow Sea North Road, Rongcheng harbour office, Weihai, Shandong Applicant after: Li Xin Address before: 264309, No. 100 Ann Ann Road, Rongcheng, Shandong, Weihai Applicant before: Zhao Xia |
|
| CB03 | Change of inventor or designer information |
Inventor after: Li Xin Inventor after: Qu Xiaorong Inventor after: Zhao Xia Inventor before: Zhao Xia |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150610 Termination date: 20160318 |